Literature DB >> 723638

Pathogenesis of glucose intolerance in uremia.

R A DeFronzo.   

Abstract

The pathogenesis of glucose intolerance in uremia was examined with the glucose clamp technique. Hyperglycemic clamp (n = 8): The plasma glucose concentration is acutely raised and maintained at 125 mg/dl above basal levels. Under these steady state conditions the glucose infusion rate, M, equals the amount of glucose metabolized: Predialysis M averaged 4.23 +/- 0.36 mg/kg/min and increased to 7.71 +/- 0.43 postdialysis (p less than 0.001). The plasma insulin response predialysis was 90 +/- 20 microU/ml and decreased to 80 +/- 23 microU/ml following dialysis. Consequently the M/l ratio, a measure of tissue sensitivity to insulin, increased by 80% +/- 25% (p less than 0.001) but still remained less than controls (p less than 0.01). Euglycemic insulin clamp (n = 10): The plasma insulin concentration is acutely raised by 100 microU/ml and the plasma glucose concentration is held constant at the basal level. Predialysis both M (3.37 +/- 0.36 mg/kg/min) and M/l (3.56 +/- 0.33 mg/kg/min per microU/ml X 100) were significantly less than controls (p less than 0.01). Postdialysis both M and M/l increased significantly (p less than 0.01) to a mean that was not significantly different from controls. Basal hepatic glucose production (n = 6), 2.15 +/- 0.09 mg/kg/min, was similar to controls and fell (87% +/- 4%) normally during the insulin clamp. In five uremic subjects in wom insulin binding to monocytes was measured, there was no correlation with tissue sensitivity to insulin (M/l). Significant abnormalities in both growth hormone and glucagon physiology were present in uremic individuals, but no correlation with either the presence or degree of glucose intolerance was demonstrable. In conclusion, glucose intolerance is universally present in uremic subjects and results primarily from peripheral tissue insensitivity to insulin. Insulin secretion is usually enhanced in an attempt to compensate for this insulin resistance but in occasional subjects uremia also inhibits beta cell sensitivity to glucose. Hepatic glucose production is unaffected by uremia. The lack of correlation between insulin binding and tissue sensitivity to insulin suggests that the cellular mechanism accounting for the insulin resistance is probably the result of a defect in intracellular metabolism or in the glucose transport system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 723638     DOI: 10.1016/s0026-0495(78)80005-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

Review 1.  Measurement of insulin resistance in chronic kidney disease.

Authors:  Hien Pham; Kristina M Utzschneider; Ian H de Boer
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-11       Impact factor: 2.894

2.  A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients.

Authors:  Adriana M Hung; Mary B Sundell; Phyllis Egbert; Edward D Siew; Ayumi Shintani; Charles D Ellis; Aihua Bian; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

3.  Secondary hyperparathyroidism and target organs in chronic kidney disease.

Authors:  M Nikodimopoulou; S Liakos
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

4.  Glucocorticoid-induced insulin resistance: the importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytes.

Authors:  J F Caro; J M Amatruda
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

5.  Coronary-artery calcium scores using electron beam CT in patients with chronic renal failure.

Authors:  Chan-Duck Kim; Ji-Hyung Cho; Hyuk-Joon Choi; Min-Hwa Jang; Hyeog-Man Kwon; Jun-Chul Kim; Sun-Hee Park; Jong-Min Lee; Dong-Kyu Cho; Yong-Lim Kim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

6.  Insulin resistance in uremia. Characterization of insulin action, binding, and processing in isolated hepatocytes from chronic uremic rats.

Authors:  J M Kauffman; J F Caro
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

7.  Role of parathyroid hormone in the glucose intolerance of chronic renal failure.

Authors:  M Akmal; S G Massry; D A Goldstein; P Fanti; A Weisz; R A DeFronzo
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

8.  Blood levels of branched-chain alpha-keto acids in uremia: effect of an oral glucose tolerance test.

Authors:  P Schauder; D Matthaei; H V Henning; F Scheler; U Langenbeck
Journal:  Klin Wochenschr       Date:  1981-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.